SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Hutchmed (China)
HCM
Halozyme Therapeutics
HALO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 5.38%157.54M | 0.83%154.28M | 20.14%153.29M | -38.35%576.29M | 0.47%146.18M | -11.41%149.51M | -69.46%153.01M | 6.81%127.59M | 118.34%934.74M | 10.25%145.5M |
Net income from continuing operations | -7.63%123M | -3.99%141.15M | 2.94%150.5M | 3.06%576.3M | -1.83%149.92M | 99.34%133.16M | 1,687.71%147.02M | -55.89%146.2M | -46.89%559.21M | -8.00%152.72M |
Operating gains losses | -49.91%5.4M | -227.09%-8.32M | -641.10%-9.97M | -106.96%-9.64M | -11.19%-19.71M | -90.04%10.77M | -101.73%-2.54M | 101.87%1.84M | 119.24%138.43M | 65.47%-17.72M |
Depreciation and amortization | 38.76%38.73M | 31.81%34.34M | 21.49%30.37M | 39.31%108.07M | 28.93%29.11M | 37.83%27.91M | 44.43%26.06M | 49.59%24.99M | -13.14%77.57M | 43.68%22.58M |
Other non cash items | -218.01%-4.86M | -493.96%-2.55M | 143.14%2.04M | -641.26%-8.64M | -372.94%-3.04M | -195.36%-1.53M | -89.09%646K | -49.24%-4.72M | -92.80%1.6M | -121.37%-643K |
Change In working capital | 69.66%-6.31M | 34.31%-11.94M | 47.90%-21.22M | -167.43%-102.47M | -33.75%-22.78M | 20.27%-20.8M | -105.64%-18.17M | 67.94%-40.72M | 575.43%151.96M | -60.16%-17.03M |
-Change in receivables | 172.92%5.89M | -340.60%-6.65M | -1,145.83%-1.51M | -104.11%-21.73M | -324.58%-12.28M | -983.59%-8.08M | 80.64%-1.51M | 116.63%144K | -5,475.76%-10.64M | -281.49%-2.89M |
-Change in inventory | -120.52%-1.78M | -416.97%-1.71M | 958.48%4.31M | -138.98%-8.41M | -3,113.39%-7.68M | 42.95%-809K | 83.95%-330K | 110.88%407K | -70.21%-3.52M | 55.90%-239K |
-Change in prepaid assets | -76.12%293K | 140.67%473K | -166.25%-426K | -183.75%-603K | -146.64%-507K | 51.11%1.23M | 9.49%-1.16M | -250.94%-160K | 165.69%720K | 210.24%1.09M |
-Change in payables and accrued expense | -44.56%-6.73M | 520.22%12M | -22.48%-6.23M | -102.63%-154K | 17.40%7.65M | 15.35%-4.65M | 341.75%1.93M | -190.14%-5.09M | -55.96%5.86M | -27.70%6.52M |
-Change in other current assets | -53.24%4.39M | 798.31%7.86M | 154.47%6.06M | 114.92%7.81M | 187.71%10.68M | 193.58%9.38M | -101.10%-1.13M | 91.63%-11.12M | -26.84%-52.35M | 49.44%-12.18M |
-Change in other current liabilities | -385.84%-6.44M | -1,409.79%-11.11M | -94.29%-7.08M | -103.46%-1.86M | -105.85%-1.31M | -86.75%2.25M | -88.50%848K | -153.31%-3.65M | 27,051.76%53.63M | 19,058.12%22.42M |
-Change in other working capital | 90.42%-1.93M | 23.90%-12.8M | 23.12%-16.34M | -148.99%-77.53M | 39.09%-19.33M | 27.84%-20.13M | -107.51%-16.82M | -250.26%-21.26M | 19,121.03%158.26M | -845.57%-31.74M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 5.38%157.54M | 0.83%154.28M | 20.14%153.29M | -38.35%576.29M | 0.47%146.18M | -11.41%149.51M | -69.46%153.01M | 6.81%127.59M | 118.34%934.74M | 10.25%145.5M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -145.25%-241.02M | -120.62%-207.81M | -1,928.12%-123.41M | -291.72%-338.53M | -1,259.90%-139.98M | -165.42%-98.27M | -2,929.44%-94.19M | -155.54%-6.09M | 223.35%176.57M | 130.68%12.07M |
Net PPE purchase and sale | -144.01%-239.8M | -764.13%-207.81M | -6,673.38%-123.41M | -276.96%-264.12M | -1,259.90%-139.98M | -786.39%-98.27M | 70.67%-24.05M | -116.63%-1.82M | 80.30%-70.07M | 113.17%12.07M |
Net business purchase and sale | ---1.23M | --0 | --0 | ---74.41M | --0 | --0 | ---70.14M | ---4.26M | --0 | --0 |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16.03%246.64M | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -145.25%-241.02M | -120.62%-207.81M | -1,928.12%-123.41M | -291.72%-338.53M | -1,259.90%-139.98M | -165.42%-98.27M | -2,929.44%-94.19M | -155.54%-6.09M | 223.35%176.57M | 130.68%12.07M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 349.18%95.37M | 181.28%101.65M | 176.48%22.64M | 76.00%-233.62M | 91.14%-40.68M | 53.45%-38.27M | 66.24%-125.07M | 51.88%-29.6M | -340.71%-973.4M | -713.72%-459.24M |
Net issuance payments of debt | 1,724.87%111.71M | 262.80%119.13M | 456.38%48.13M | 88.37%-100.43M | 98.45%-6.88M | 84.39%-6.88M | 78.19%-73.17M | 66.73%-13.5M | -449.41%-863.75M | -989.35%-443.61M |
Net common stock issuance | 97.04%-492K | 96.89%-1.09M | -610.67%-4.13M | -147.29%-70.61M | ---18.28M | 25.34%-16.6M | -455.84%-35.16M | ---581K | ---28.55M | --0 |
Cash dividends paid | -4.55%-15.48M | -2.50%-15.48M | -1.79%-15.54M | 1.28%-60.7M | -2.29%-15.53M | 2.80%-14.8M | 2.81%-15.1M | 1.76%-15.26M | -99.06%-61.48M | -47.51%-15.19M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 349.18%95.37M | 181.28%101.65M | 176.48%22.64M | 76.00%-233.62M | 91.14%-40.68M | 53.45%-38.27M | 66.24%-125.07M | 51.88%-29.6M | -340.71%-973.4M | -713.72%-459.24M |
Net cash flow | ||||||||||
Beginning cash position | 26.97%372.45M | -9.80%324.33M | 1.55%271.81M | 106.29%267.67M | -46.20%306.29M | -11.80%293.33M | 81.00%359.58M | 106.29%267.67M | 97.61%129.76M | 508.55%569.34M |
Current changes in cash | -8.25%11.89M | 172.64%48.12M | -42.86%52.52M | -97.00%4.14M | 88.57%-34.48M | -94.53%12.96M | -149.47%-66.25M | 33.38%91.91M | 115.17%137.91M | -933.38%-301.68M |
End cash Position | 25.48%384.34M | 26.97%372.45M | -9.80%324.33M | 1.55%271.81M | 1.55%271.81M | -46.20%306.29M | -11.80%293.33M | 81.00%359.58M | 106.29%267.67M | 106.29%267.67M |
Free cash flow | -259.68%-81.81M | -149.20%-63.45M | -76.07%29.17M | -58.09%308.26M | -85.05%6.2M | -67.51%51.23M | -69.22%128.96M | 3.78%121.86M | 916.16%735.61M | 2.89%41.5M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |